NCT00087542View on ClinicalTrials.gov

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

December 31, 2005

Conditions
HallucinationsPsychosesParkinson's Disease
Interventions
DRUG

ACP-103

Trial Locations (13)

12205

Albany

19107

Philadelphia

21075

Elkridge

28806

Asheville

30329

Atlanta

33060

Pompano Beach

33606

Tampa

37027

Brentwood

66160

Kansas City

92708

Fountain Valley

94089

Sunnyvale

06810

Danbury

02860

Pawtucket

Sponsors
All Listed Sponsors
lead

ACADIA Pharmaceuticals Inc.

INDUSTRY